{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T13:30:28Z","timestamp":1785850228913,"version":"3.56.0"},"reference-count":32,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objectives: Submacular hemorrhage (SMH) associated with neovascular age-related macular degeneration (nAMD) can lead to significant vision loss, and the optimal management strategy remains uncertain. This study aimed to evaluate the efficacy and safety of pneumatic displacement (PD) without tissue plasminogen activator (t-PA) for SMH secondary to nAMD. Methods: A retrospective analysis was conducted on 22 eyes with SMH secondary to nAMD treated with PD without t-PA. Best-corrected visual acuity (BCVA), central retinal thickness (CRT), number of intravitreal injections, and postoperative complications were assessed at baseline and follow-up. Multiple logistic regression analyses were used to identify factors associated with visual outcomes. Results: In the 22 eyes that completed the 6-month follow-up, BCVA (logMAR) was 0.88 \u00b1 0.46 at baseline and 0.76 \u00b1 0.63 at 6 months (p = 0.24). In the 15 eyes with 12-month follow-up, BCVA improved significantly from 0.92 \u00b1 0.47 at baseline to 0.56 \u00b1 0.51 at 12 months (p = 0.01). CRT significantly decreased at 3 months (p &lt; 0.01). During this period, patients received an average of 8.13 \u00b1 2.90 intravitreal anti-vascular endothelial growth factor (VEGF) injections. A shorter duration from symptom onset to treatment was associated with better visual outcomes (p = 0.02). Postoperative vitreous hemorrhage occurred in 31.8% of cases. Conclusions: PD without t-PA, in combination with anti-VEGF therapy, improved visual outcomes over 12 months. Early intervention and continuous anti-VEGF administration appear to be key factors in optimizing treatment outcomes. Further studies are needed to establish standardized treatment protocols for SMH associated with nAMD.<\/jats:p>","DOI":"10.3390\/jcm14093154","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T07:44:23Z","timestamp":1746171863000},"page":"3154","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pneumatic Displacement and Anti-VEGF Therapy for Submacular Hemorrhage in Neovascular Age-Related Macular Degeneration: A Retrospective Study"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-3052-9391","authenticated-orcid":false,"given":"Hikaru","family":"Ota","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa, Nagoya 466-8550, Aichi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Takeuchi","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa, Nagoya 466-8550, Aichi, Japan"},{"name":"Department of Ophthalmology, Kyorin University School of Medicine, 6-20-2 Shinkawa, Mitaka 181-8611, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Nonogaki","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa, Nagoya 466-8550, Aichi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuma","family":"Tamura","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa, Nagoya 466-8550, Aichi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taro","family":"Kominami","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa, Nagoya 466-8550, Aichi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,5,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1001\/archopht.121.11.1621","article-title":"Potential Public Health Impact of Age-Related Eye Disease Study Results: AREDS Report No. 11","volume":"121","author":"Bressler","year":"2003","journal-title":"Arch. Ophthalmol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1001\/archopht.122.4.564","article-title":"Prevalence of Age-Related Macular Degeneration in the United States","volume":"122","author":"Friedman","year":"2004","journal-title":"Arch. Ophthalmol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1001\/archopht.1991.01080050139046","article-title":"Fibrin Directs Early Retinal Damage After Experimental Subretinal Hemorrhage","volume":"109","author":"Toth","year":"1991","journal-title":"Arch. Ophthalmol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e1569","DOI":"10.1111\/aos.15137","article-title":"Incidence, Risk Factors and Outcomes of Submacular Haemorrhage with Loss of Vision in Neovascular Age-related Macular Degeneration in Daily Clinical Practice: Data from the FRB! Registry","volume":"100","author":"Gabrielle","year":"2022","journal-title":"Acta Ophthalmol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/eye.2015.131","article-title":"Intravitreal Anti-Vascular Endothelial Growth Factor Monotherapy for Large Submacular Hemorrhage Secondary to Neovascular Age-Related Macular Degeneration","volume":"29","author":"Kim","year":"2015","journal-title":"Eye"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.ajo.2015.01.024","article-title":"Anti\u2013Vascular Endothelial Growth Factor with or Without Pneumatic Displacement for Submacular Hemorrhage","volume":"159","author":"Shin","year":"2015","journal-title":"Am. J. Ophthalmol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1007\/s00417-022-05922-0","article-title":"Simultaneous Intravitreal Aflibercept and Gas Injections for Submacular Hemorrhage Secondary to Polypoidal Choroidal Vasculopathy","volume":"261","author":"Wakabayashi","year":"2023","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.survophthal.2015.04.004","article-title":"Submacular Hemorrhage in Neovascular Age-Related Macular Degeneration: A Synthesis of the Literature","volume":"61","author":"Balta","year":"2016","journal-title":"Surv. Ophthalmol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40942-020-00228-x","article-title":"Surgical Management of Submacular Hemorrhage Due to N-AMD: A Comparison of Three Surgical Methods","volume":"6","author":"Grohmann","year":"2020","journal-title":"Int. J. Retin. Vitr."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/opo.12131","article-title":"When to Use the Bonferroni Correction","volume":"34","author":"Armstrong","year":"2014","journal-title":"Ophthalmic Physiol. Opt."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s10384-021-00869-x","article-title":"Visual Acuity Outcomes of Anti-VEGF Treatment for Neovascular Age-Related Macular Degeneration in Clinical Trials","volume":"65","author":"Yamashiro","year":"2021","journal-title":"Jpn. J. Ophthalmol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Inoue, N., Kato, A., Araki, T., Kimura, T., Kinoshita, T., Okamoto, F., Murakami, T., Mitamura, Y., Sakamoto, T., and Miki, A. (2022). Visual Prognosis of Submacular Hemorrhage Secondary to Age-Related Macular Degeneration: A Retrospective Multicenter Survey. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0271447"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e1579","DOI":"10.1111\/aos.15149","article-title":"Comparison of Visual Outcomes of Polypoidal Choroidal Vasculopathy and Typical Neovascular Age-related Macular Degeneration\u2014Up to 10 Years of Follow-up","volume":"100","author":"Park","year":"2022","journal-title":"Acta Ophthalmol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1007\/s00417-021-05293-y","article-title":"Relationship between Retinal Fluid and Visual Acuity in Patients with Exudative Age-Related Macular Degeneration Treated with Intravitreal Aflibercept Using a Treat-and-Extend Regimen: Subgroup and Post-Hoc Analyses from the ALTAIR Study","volume":"259","author":"Ohji","year":"2021","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/eye.2016.65","article-title":"Vitrectomy with Subretinal Tissue Plasminogen Activator and Ranibizumab for Submacular Haemorrhages Secondary to Age-Related Macular Degeneration: Retrospective Case Series of 45 Consecutive Cases","volume":"30","author":"McGowan","year":"2016","journal-title":"Eye"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1097\/IAE.0000000000002762","article-title":"Visual Prognosis after Pneumatic Displacement of Submacular Hemorrhage According to Age-Related Macular. Degeneration Subtypes","volume":"40","author":"Lee","year":"2020","journal-title":"Retina"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0002-9394(00)00734-0","article-title":"Pars Plana Vitrectomy, Subretinal Injection of Tissue Plasminogen Activator, and Fluid\u2013Gas Exchange for Displacement of Thick Submacular Hemorrhage in Age-Related Macular Degeneration","volume":"131","author":"Haupert","year":"2001","journal-title":"Am. J. Ophthalmol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s00417-002-0516-5","article-title":"Tissue Plasminogen Activator plus Gas Injection in Patients with Subretinal Hemorrhage Caused by Age-Related Macular Degeneration: Predictive Variables for Visual Outcome","volume":"240","author":"Schulze","year":"2002","journal-title":"Graefe S Arch. Clin. Exp. Ophthalmol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1097\/IAE.0b013e31822528c8","article-title":"Vitreous Hemorrhage Complicating Intravitreal Tissue Plasminogen Activator and Pneumatic Displacement of Submacular Hemorrhage","volume":"31","author":"Wu","year":"2011","journal-title":"Retina"},{"key":"ref_20","first-page":"41","article-title":"Comparison of the Short-Term Efficacy of Intravitreal Aflibercept and Ranibizumab for Macular Edema Caused by Branch Retinal Vein Occlusion","volume":"41","author":"Matsuo","year":"2024","journal-title":"Shimane J. Med. Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/IAE.0b013e3182670fbe","article-title":"Photodynamic Therapy for Chronic Central Serous Chorioretinopathy","volume":"33","author":"Silva","year":"2013","journal-title":"Retina"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/eye.2016.67","article-title":"Early Treatment of Acute Submacular Haemorrhage Secondary to Wet AMD Using Intravitreal Tissue Plasminogen Activator, C3F8, and an Anti-VEGF Agent","volume":"30","author":"Bindra","year":"2016","journal-title":"Eye"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/01.iae.0000237586.48231.75","article-title":"Management of Submacular Hemorrhage with Intravitreal Injection of Tissue Plasminogen Activator and Expansile Gas","volume":"27","author":"Chen","year":"2007","journal-title":"Retina"},{"key":"ref_24","first-page":"28","article-title":"Treatment of Submacular Hemorrhage with Low-Dose Intravitreal Tissue Plasminogen Activator Injection and Pneumatic Displacement","volume":"119","author":"Handwerger","year":"2001","journal-title":"Arch. Ophthalmol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1097\/IAE.0000000000001030","article-title":"Tissue Plasminogen Activator for Subfoveal Hemorrhage Due to Age-Related Macular Degeneration","volume":"36","author":"Fassbender","year":"2016","journal-title":"Retina"},{"key":"ref_26","first-page":"565","article-title":"Pneumatic Displacement of Acute Submacular Hemorrhage with and without the Use of Tissue Plasminogen Activator","volume":"20","author":"Yilmaz","year":"2009","journal-title":"Eur. J. Ophthalmol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1097\/IAE.0b013e318287d99d","article-title":"Comparison Of Pneumatic Displacement for Submacular Hemorrhages with Gas Alone and Gas Plus Tissue Plasminogen Activator","volume":"33","author":"Fujikawa","year":"2013","journal-title":"Retina"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ophtha.2014.07.027","article-title":"Displacement of Submacular Hemorrhages in Age-Related Macular Degeneration with Subretinal Tissue Plasminogen Activator and Air","volume":"122","author":"Kadonosono","year":"2015","journal-title":"Ophthalmology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0002-9394(14)70274-0","article-title":"Surgical Removal of Submacular Hemorrhage Using Tissue Plasminogen Activator and Perfluorocarbon Liquid","volume":"121","author":"Kamei","year":"1996","journal-title":"Am. J. Ophthalmol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"6501","DOI":"10.1167\/iovs.15-17279","article-title":"Ranibizumab and Aflibercept: Intraocular Pharmacokinetics and Their Effects on Aqueous VEGF Level in Vitrectomized and Nonvitrectomized Macaque Eyes","volume":"56","author":"Niwa","year":"2015","journal-title":"Investig. Opthalmol. Vis. Sci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.ophtha.2023.04.014","article-title":"STAR: A Randomized Controlled Trial for Submacular Hemorrhage Secondary to Age-Related Macular Degeneration","volume":"130","author":"Gabrielle","year":"2023","journal-title":"Ophthalmology"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Jeong, S., Park, D.-G., and Sagong, M. (2020). Management of a Submacular Hemorrhage Secondary to Age-Related Macular Degeneration: A Comparison of Three Treatment Modalities. J. Clin. Med., 9.","DOI":"10.3390\/jcm9103088"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/9\/3154\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:26:19Z","timestamp":1760030779000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/9\/3154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,2]]},"references-count":32,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["jcm14093154"],"URL":"https:\/\/doi.org\/10.3390\/jcm14093154","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,2]]}}}